Laurus Labs is quickly establishing itself as one of the leading names in API manufacturing. With multiple manufacturing sites and capabilities in a wide range of areas including high potent molecules, Laurus Labs is using its expertise in process chemistry to set new standards in competitive supply of high quality materials. Having successfully hosted GMP inspections by the FDA, TGA and MHRA, as well as obtaining CEPs from EDQM for several molecules, the company is now embarking on a capacity expansion plan that will see it become one of the largest manufacturing units in India within the next 24 months.

Since its foundation in 2005, Laurus Labs has established a large portfolio of molecules in commercial production along with several more in active development. Laurus Labs offers a full range of Anti Retroviral API and Oncology API as well as several other API where an expertise in chemistry can lead to commercial advantage. Multiple DMFs for these APIs have been filed in the past three years in US, EU, Australia, Canada, Singapore and New Zealand and Japan.

Making use of its core-strengths of innovative, robust & scalable chemistry, Laurus labs has assisted multiple client organizations involved in new drug development across USA, EU & rest of world by providing NCE services, solutions across all stages of drug lifecycle right from route identification, CMC data generation through to GMP manufacture. The drug substance services are complemented by the comprehensive analytical development & product development services.

In addition to the above, Laurus labs through its innovative & patented technologies has been in the forefront of developing & manufacture of highly pure, well characterized specialty ingredients for use in nutraceutical/ dietary supplements & cosmeceutical products.